lysine has been researched along with ginsenosides in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, H; Choi, SH; Choi, WS; Kim, DH; Kim, YI; Lee, BH; Lee, JH; Lim, Y; Lim, YW; Nah, SY; Pyo, MK; Rhim, H; Shin, TJ; Won, KH; Yoon, IS | 1 |
| Choi, SH; Kim, HC; Lee, BH; Lee, JH; Lee, SM; Nah, SY; Pyo, MK; Shin, TJ; Yoon, IS | 1 |
| Choe, H; Choi, SH; Chu, DH; Hwang, SH; Kim, BR; Kim, DH; Kim, HC; Lee, BH; Lee, JH; Lee, SM; Nah, SY; Pyo, MK; Rhim, HW; Shin, TJ | 1 |
| Kang, KS; Kim, HY; Park, JH; Yamabe, N; Yokozawa, T | 1 |
| Cho, EJ; Ham, J; Kang, KS; Kim, HY; Kim, YJ; Lee, S; Park, SH; Yamabe, N | 1 |
| Lin, CP; Shen, LJ; Wang, YL | 1 |
6 other study(ies) available for lysine and ginsenosides
| Article | Year |
|---|---|
Ginsenoside Rg3 inhibits human Kv1.4 channel currents by interacting with the Lys531 residue.
Topics: Amino Acid Substitution; Animals; Binding Sites; Dose-Response Relationship, Drug; Female; Ginsenosides; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Kv1.4 Potassium Channel; Lysine; Models, Molecular; Molecular Structure; Oocytes; Patch-Clamp Techniques; Potassium Channel Blockers; Protein Binding; Tetraethylammonium; Xenopus laevis | 2008 |
Involvement of batrachotoxin binding sites in ginsenoside-mediated voltage-gated Na+ channel regulation.
Topics: Animals; Batrachotoxins; Binding Sites; Dose-Response Relationship, Drug; Ginsenosides; Ion Channel Gating; Leucine; Lysine; Mice; Microinjections; Muscle Proteins; Muscle, Skeletal; NAV1.2 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Neurotoxins; Oocytes; Patch-Clamp Techniques; Point Mutation; Protein Structure, Tertiary; Rats; Sodium Channels; Xenopus laevis | 2008 |
Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
Topics: Action Potentials; Animals; Base Sequence; Catalytic Domain; Dose-Response Relationship, Drug; Ginsenosides; Humans; Ion Channel Gating; KCNQ1 Potassium Channel; Lysine; Mutation; Oocytes; Panax; Potassium Channels, Voltage-Gated; Protein Subunits; Valine; Xenopus laevis | 2010 |
Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Antioxidants; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ginsenosides; Glycation End Products, Advanced; Hypoglycemic Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Lipids; Lysine; Male; Nitric Oxide Synthase Type II; Oxidative Stress; Panax; Phytotherapy; Plant Extracts; Proteinuria; Rats; Rats, Inbred OLETF; Thiobarbituric Acid Reactive Substances | 2010 |
Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Cell Proliferation; Ginsenosides; Humans; Lysine; Maillard Reaction; Molecular Structure; Panax | 2013 |
The dentin permeability of anti-inflammatory and antibacterial drugs: In vitro study.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Betamethasone; Dentin; Dentin Permeability; Ginsenosides; Humans; Lysine; Microscopy, Electron, Scanning | 2019 |